Literature DB >> 25855579

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.

Veronika Mancikova1, Raquel Cruz2,3, Lucía Inglada-Pérez1,3, Ceres Fernández-Rozadilla2,4, Iñigo Landa5, José Cameselle-Teijeiro6, Catuxa Celeiro2,6, Susana Pastor7,8, Antonia Velázquez7,8, Ricard Marcos7,8, Victor Andía9, Cristina Álvarez-Escolá10, Amparo Meoro11, Francesca Schiavi12, Giuseppe Opocher12,13, Inés Quintela14, Juan Ansede-Bermejo14, Clara Ruiz-Ponte2,3, Pilar Santisteban15, Mercedes Robledo1,3, Angel Carracedo2,3,14.   

Abstract

Thyroid cancer is the most heritable cancer of all those not displaying typical Mendelian inheritance. However, most of the genetic factors that would explain the high heritability remain unknown. Our aim was to identify additional common genetic variants associated with susceptibility to this disease. In order to do so, we performed a genome-wide association study in a series of 398 cases and 502 controls from Spain, followed by a replication in four well-defined Southern European case-control collections contributing a total of 1,422 cases and 1,908 controls. The association between the variation at the 9q22 locus near FOXE1 and thyroid cancer risk was consistent across all series, with several SNPs identified (rs7028661: OR = 1.64, p = 1.0 × 10(-22) , rs7037324: OR = 1.54, p = 1.2 × 10(-17) ). Moreover, the rare alleles of three SNPs (rs2997312, rs10788123 and rs1254167) at 10q26.12 showed suggestive evidence of association with higher risk of the disease (OR = 1.35, p = 1.2 × 10(-04) , OR = 1.26, p = 5.2 × 10(-04) and OR = 1.38, p = 5.9 × 10(-05) , respectively). Finally, the rare allele of rs4075570 at 6q14.1 conferred protection in the series studied (OR = 0.82, p = 2.0 × 10(-04) ). This study suggests that heterogeneity in genetic susceptibility between populations is a key feature to take into account when exploring genetic risk factors related to this disease.
© 2015 UICC.

Entities:  

Keywords:  FOXE1; HTR1B; genetic heterogeneity; susceptibility; thyroid cancer

Mesh:

Year:  2015        PMID: 25855579     DOI: 10.1002/ijc.29557

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  A genome-wide association study yields five novel thyroid cancer risk loci.

Authors:  Julius Gudmundsson; Gudmar Thorleifsson; Jon K Sigurdsson; Lilja Stefansdottir; Jon G Jonasson; Sigurjon A Gudjonsson; Daniel F Gudbjartsson; Gisli Masson; Hrefna Johannsdottir; Gisli H Halldorsson; Simon N Stacey; Hannes Helgason; Patrick Sulem; Leigha Senter; Huiling He; Sandya Liyanarachchi; Matthew D Ringel; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; Li Xu; Lambertus A Kiemeney; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; Hoskuldur Kristvinsson; Romana T Netea-Maier; Thorvaldur Jonsson; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Unnur Thorsteinsdottir; Thorunn Rafnar; Albert de la Chapelle; Kari Stefansson
Journal:  Nat Commun       Date:  2017-02-14       Impact factor: 14.919

2.  Assessing thyroid cancer risk using polygenic risk scores.

Authors:  Sandya Liyanarachchi; Julius Gudmundsson; Egil Ferkingstad; Huiling He; Jon G Jonasson; Vinicius Tragante; Folkert W Asselbergs; Li Xu; Lambertus A Kiemeney; Romana T Netea-Maier; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Pamela Brock; Fadi Nabhan; Gudmar Thorleifsson; Matthew D Ringel; Kari Stefansson; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

3.  Identification of Rare Variants Predisposing to Thyroid Cancer.

Authors:  Yanqiang Wang; Sandya Liyanarachchi; Katherine E Miller; Taina T Nieminen; Daniel F Comiskey; Wei Li; Pamela Brock; David E Symer; Keiko Akagi; Katherine E DeLap; Huiling He; Daniel C Koboldt; Albert de la Chapelle
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

Review 4.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

5.  Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer.

Authors:  Nan Song; Qi Liu; Yutaka Yasui; Zhaoming Wang; Carmen L Wilson; Yadav Sapkota; Matthew J Ehrhardt; Todd M Gibson; Lindsay M Morton; Stephen J Chanock; Joseph P Neglia; Michael A Arnold; J Robert Michael; Alexander M Gout; Heather L Mulder; John Easton; Smita Bhatia; Gregory T Armstrong; Jinghui Zhang; Angela Delaney; Melissa M Hudson; Leslie L Robison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-31       Impact factor: 4.090

6.  Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.

Authors:  Jaroslaw Jendrzejewski; Sandya Liyanarachchi; Rebecca Nagy; Leigha Senter; Paul E Wakely; Andrew Thomas; Fadi Nabhan; Huiling He; Wei Li; Krzysztof Sworczak; Matthew D Ringel; Lawrence S Kirschner; Albert de la Chapelle
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

7.  Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.

Authors:  Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

8.  Genome-wide association studies and epigenome-wide association studies go together in cancer control.

Authors:  Mukesh Verma
Journal:  Future Oncol       Date:  2016-04-15       Impact factor: 3.404

9.  Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.

Authors:  Ho-Young Son; Yul Hwangbo; Seong-Keun Yoo; Sun-Wha Im; San Duk Yang; Soo-Jung Kwak; Min Seon Park; Soo Heon Kwak; Sun Wook Cho; Jun Sun Ryu; Jeongseon Kim; Yuh-Seog Jung; Tae Hyun Kim; Su-Jin Kim; Kyu Eun Lee; Do Joon Park; Nam Han Cho; Joohon Sung; Jeong-Sun Seo; Eun Kyung Lee; Young Joo Park; Jong-Il Kim
Journal:  Nat Commun       Date:  2017-07-13       Impact factor: 14.919

10.  Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia).

Authors:  María Sánchez-Ares; José M Cameselle-Teijeiro; Sergio Vázquez-Estévez; Martín Lázaro-Quintela; Ángel Vázquez-Boquete; Francisco J Afonso-Afonso; Joaquín Casal-Rubio; Ana L González-Piñeiro; Yolanda Rico-Rodríguez; José L Fírvida-Pérez; Juan Ruíz-Bañobre; Elena Couso; Lucía Santomé; Raquel Pérez-Becerra; Rosario García-Campelo; Margarita Amenedo; Cristina Azpitarte-Raposeiras; José Antúnez; Ihab Abdulkader
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.